ijms-logo

Journal Browser

Journal Browser

Role of Lipids in Cancer

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".

Deadline for manuscript submissions: closed (28 February 2022) | Viewed by 5005

Special Issue Editors


E-Mail Website
Guest Editor
Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, 20122 Milan, Italy
Interests: lipid biochemistry; lipidomics; Omega-3; cancer biology; applied nutrition; space life sciences

E-Mail Website
Guest Editor
Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan, Italy
Interests: lipid metabolism; inflammation; cancer biology

Special Issue Information

Dear Colleagues,

Lipids are a heterogeneous class of biomolecules which altered metabolism is one of the key features of cancer, relevant for development, chemotherapy and immunotherapy. Indeed, lipids modulate cell signaling through the lipid–protein and lipid–lipid interactions and membrane dynamics; increasing lipid content promotes cell proliferation, tumor progression, and chemotherapy resistance and fatty acids are needed for energy storage, membrane structure, and precursors of signaling molecules. Most of the enzymes and carriers involved in lipid procurement and synthesis are abnormally expressed in cancer cells and in some conditions their chemical and genetic inhibition effects cancer viability and immune response. Therefore, this Special Issue will describe recent advances in the understanding of the role of lipids and their metabolites on cancer progression and therapy success. For this aim, we will present studies that highlight the impact of peculiar lipid phenotype on cancer progression and immune cell phenotyping. In addition, this Special Issue could be an opportunity to present new molecular and/or cellular mechanisms of action of lipids and to propose new targets to ameliorate the anticancer strategies.

Dr. Angela Maria Rizzo
Dr. Paola Antonia Corsetto
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • lipid
  • lipid metabolism
  • tumor progression
  • immunotherapy
  • lipid–protein interactions
  • fatty acids

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

21 pages, 44646 KiB  
Article
Gene Expression of the D-Series Resolvin Pathway Predicts Activation of Anti-Tumor Immunity and Clinical Outcomes in Head and Neck Cancer
by Domenico Mattoscio, Giulia Ferri, Claudia Miccolo, Susanna Chiocca, Mario Romano and Antonio Recchiuti
Int. J. Mol. Sci. 2022, 23(12), 6473; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms23126473 - 09 Jun 2022
Cited by 2 | Viewed by 1951
Abstract
In human medicine, the progression from early neoplasia development to either complete resolution of tumorigenesis and associated inflammation or chronicity and fatal outcomes remain difficult to predict. Resolution of inflammation is an active process that stimulates the termination of the inflammatory response and [...] Read more.
In human medicine, the progression from early neoplasia development to either complete resolution of tumorigenesis and associated inflammation or chronicity and fatal outcomes remain difficult to predict. Resolution of inflammation is an active process that stimulates the termination of the inflammatory response and promotes return to homeostasis, while failure in resolution contributes to the development of a number of diseases. To understand how resolution pathways contribute to tumorigenesis, we defined and employed a cumulative score based on the expression level of genes involved in synthesis, signaling, and metabolism of the D-series resolvin (RvD). This score was used for comparative analyses of clinical, cellular, and molecular features of tumors, based on RNA-sequencing (RNA-seq) datasets collected within The Cancer Genome Atlas (TCGA) program. Our results indicate that higher RvD scores are associated with better clinical outcome of patients with head and neck squamous cell carcinoma (HNSC), and with molecular and cellular signatures indicative of enhanced anti-tumor immunity and better response to immune-checkpoint inhibitors (ICI), also in human papilloma virus (HPV) negative HNSC subtypes. Thus, higher activity of the RvD pathway identifies patients with improved resolution and a more efficient immune reaction against cancer. Full article
(This article belongs to the Special Issue Role of Lipids in Cancer)
Show Figures

Figure 1

18 pages, 3466 KiB  
Article
Adipose Tissue—Breast Cancer Crosstalk Leads to Increased Tumor Lipogenesis Associated with Enhanced Tumor Growth
by Peter Micallef, Yanling Wu, Marco Bauzá-Thorbrügge, Belén Chanclón, Milica Vujičić, Eduard Peris, C. Joakim Ek and Ingrid Wernstedt Asterholm
Int. J. Mol. Sci. 2021, 22(21), 11881; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms222111881 - 02 Nov 2021
Cited by 10 | Viewed by 2476
Abstract
We sought to identify therapeutic targets for breast cancer by investigating the metabolic symbiosis between breast cancer and adipose tissue. To this end, we compared orthotopic E0771 breast cancer tumors that were in direct contact with adipose tissue with ectopic E0771 tumors in [...] Read more.
We sought to identify therapeutic targets for breast cancer by investigating the metabolic symbiosis between breast cancer and adipose tissue. To this end, we compared orthotopic E0771 breast cancer tumors that were in direct contact with adipose tissue with ectopic E0771 tumors in mice. Orthotopic tumors grew faster and displayed increased de novo lipogenesis compared to ectopic tumors. Adipocytes release large amounts of lactate, and we found that both lactate pretreatment and adipose tissue co-culture augmented de novo lipogenesis in E0771 cells. Continuous treatment with the selective FASN inhibitor Fasnall dose-dependently decreased the E0771 viability in vitro. However, daily Fasnall injections were effective only in 50% of the tumors, while the other 50% displayed accelerated growth. These opposing effects of Fasnall in vivo was recapitulated in vitro; intermittent Fasnall treatment increased the E0771 viability at lower concentrations and suppressed the viability at higher concentrations. In conclusion, our data suggest that adipose tissue enhances tumor growth by stimulating lipogenesis. However, targeting lipogenesis alone can be deleterious. To circumvent the tumor’s ability to adapt to treatment, we therefore believe that it is necessary to apply an aggressive treatment, preferably targeting several metabolic pathways simultaneously, together with conventional therapy. Full article
(This article belongs to the Special Issue Role of Lipids in Cancer)
Show Figures

Figure 1

Back to TopTop